EMN Research

The European Myeloma Network (EMN) is a leading academic research organization dedicated to improving the treatment and outcomes of patients with multiple myeloma and related plasma cell disorders. Founded as a network of excellence, EMN coordinates multi-center clinical trials across Europe, collaborating with pharmaceutical partners and academic institutions. The organization manages a robust pipeline of studies investigating novel modalities, including monoclonal antibodies, CAR-T therapies, and next-generation immunomodulators. EMN Research B.V. serves as the operational arm, providing trial management, data collection, and regulatory support for large-scale international hematology studies. Its research frequently defines global standards of care in hematologic oncology, with results published in top-tier medical journals. The network integrates the expertise of over 30 national trial groups to accelerate the development of curative strategies for plasma cell dyscrasias.